Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality

Share

As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.

Prof Jens Tränckner and his research assistant Alena Seidenfaden from the University of Rostock take water samples from the Warnow at the jetty of the Olympic rowing centre south of Rostock / EU4Regions
Prof Jens Tränckner and his research assistant Alena Seidenfaden from the University of Rostock take water samples from the Warnow at the jetty of the Olympic rowing centre south of Rostock / EU4Regions

The Warnow seems to be flowing uphill on this cold morning, but it is only the wind that pushes the surface in strong gusts against the direction of flow. This part of the Warnow lies in a nature reserve. The reeds along its banks are home to valuable fauna, birds nest here, and the meadows are a lush green colour even in winter. But the river is not only home to animals and plants, it is also a drinking water reservoir for the city of Rostock.

Prof Jens Tränckner and his research assistant Alena Seidenfaden are getting ready to take water samples from the Warnow River at the jetty of the Olympic rowing centre south of Rostock. The two are from the University of Rostock and are involved in the EU-funded APRIORA project. The scientists are analysing the water for drug residues. In Germany alone, 35,000 tonnes of medicines are consumed every year. Many residues find their way back into wastewater through excretion and not all wastewater treatment plants are technically equipped to filter these residues. This means that active pharmaceutical ingredients end up in drinking water.

And this is where the APRIORA project comes in. By combining measurements and modelling, the distribution of active substances in the water can be analysed. A detailed risk assessment considers the effects on the aquatic environment, human use and antibiotic resistance. This makes it possible to estimate the individual contribution of each wastewater treatment plant to water pollution.

The implementation of the APRIORA tool in the Baltic Sea region promises environmental and health benefits by enabling authorities to take targeted action to minimise risks. Effective cooperation between scientific partners and authorities is ensured through regular exchanges and training.

The long-term goal of APRIORA is to contribute to the targeted improvement of wastewater treatment in Europe and possibly to transfer the approach to other substances. Interregional cooperation not only produces directly applicable solutions but also promotes the growing European integration on a scientific and social level. Overall, the APRIORA project shows that cross-border cooperation and an interdisciplinary approach can make a significant contribution to tackling environmental problems.

Description of the project:
Cohesion policy has defined clear objectives for the 2021-2027 funding period: A smart Europe through innovation, a greener, low-carbon Europe, a more connected Europe, a more social Europe and a Europe that is closer to its citizens. Sustainable challenges are becoming the focus of society, particularly in Germany and its neighbouring countries. The "EU4regions" project will produce high-quality multimedia and journalistic information on cohesion policy and then disseminate it widely. Within 12 months, Interreg projects from western and eastern Germany and neighbouring countries/regions will be presented to highlight local challenges. The countries concerned are Poland, the Czech Republic, Austria, Switzerland, France, the Netherlands and Denmark. Our thematic focus is on sustainability, whereby we understand sustainability as a whole. Although climate issues are at the centre of attention, they are complemented by economic and social aspects. The aim is to show how EU cohesion policy affects regions and people.

EU4regions receives funding from the EU Commission.

Contact:
EU4Regions-Team
EU4Regions@newsaktuell.de

Images

Exterior view of Rostock waterworks / EU4Regions
Exterior view of Rostock waterworks / EU4Regions
Download
The municipal water tower of Rostock / EU4Regions
The municipal water tower of Rostock / EU4Regions
Download
Prof Jens Tränckner and his research assistant Alena Seidenfaden from the University of Rostock take water samples from the Warnow at the jetty of the Olympic rowing centre south of Rostock / EU4Regions
Prof Jens Tränckner and his research assistant Alena Seidenfaden from the University of Rostock take water samples from the Warnow at the jetty of the Olympic rowing centre south of Rostock / EU4Regions
Download
Prof Jens Tränckner and his research assistant Alena Seidenfaden from the University of Rostock take water samples from the Warnow at the jetty of the Olympic rowing centre south of Rostock / EU4Regions
Prof Jens Tränckner and his research assistant Alena Seidenfaden from the University of Rostock take water samples from the Warnow at the jetty of the Olympic rowing centre south of Rostock / EU4Regions
Download
Alena Seidenfaden from the University of Rostock processes a water sample in the laboratory for further analysis / EU4Regions
Alena Seidenfaden from the University of Rostock processes a water sample in the laboratory for further analysis / EU4Regions
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site29.4.2025 14:00:00 CEST | Press Release

The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene autotemcel) developed and launched by Vertex Pharmaceuticals. Biomay's recent achievement refers to an inspection by the FDA's Center for Biologics Evaluation and Research (CBER) at Biomay's headquarters manufacturing site in Vienna, Seestadt in December 2024. No observation was found, and no Form FDA 483 was issued by the authority, allowing Biomay's headquarters site to supply Cas9 for the United States. Biomay operates two independent cGMP manufacturing sites, a headquarters facility in Vienna Seestadt, and a second site in Vienna downtown. The authority’s approval of Biomay's headquarters site represents the company's second successful FDA inspection following the 2023 approval of Biomay's

Growth and innovation as cornerstones of a strong democracy and a digitally sovereign Europe29.4.2025 12:00:00 CEST | Pressmeddelande

Germany should be restored to a growth path and should give new impulse to innovation, along with its European partners. Because prosperity is a significant guarantor of a stable democracy. Digital sovereignty is the anchor of a strong Europe. Germany can once again be a country of pioneering innovation and a pacesetter for the continent. For this, comprehensive modernization of the state is indispensable. The Bertelsmann Stiftung presented its proposals at the annual press conference.

Australia’s next government must mend structural cracks appearing in its political, economic and social foundation, report finds25.4.2025 12:05:00 CEST | Pressmeddelande

- Picture is available at AP - Los Angeles/DNA - Australia boasts some of the world’s most sophisticated political institutions and one of its wealthiest economies. But this veneer of success masks deeper structural issues — and a “ticking time bomb” of overreliance on extractive industries must be addressed under Australia’s next government, a new report recommends.

DYMO® LETRATAG 200B VINNER DET PRESTIGEFYLLDA PRISET ”BUSINESS PRODUCT OF THE YEAR” - STRUKTURERAR OCH ORGANISERAR VARDAGEN24.4.2025 16:44:06 CEST | Press Release

Amsterdam – vikten av organisering, effektivitet och produktivitet i både personliga och professionella sammanhang har aldrig varit större. Detta då allt fler använder smarta lösningar för att förenkla sin vardag. DYMO®, en ledande leverantör av innovativa etikett- och utskriftslösningar, ligger här i framkant. Som ett erkännande har DYMO LetraTag 200B belönats med EOPA Best Business Product Award, en utmärkelse som lyfter fram hur den förenklat organisering både hemma och på kontoret. "Trenden mot smart självorganisering fortsätter", berättar Liesbet De Soomer, Global Marketing Director på DYMO. "LetraTag 200B stödjer utveckligen genom att erbjuda en användarvänlig lösning, som gör märkningen snabb och enkel. Med det här verktyget kan användaren strukturera vardagskaoset och organisera tillvaron.” EOPA Best Business Product Award, som delas ut årligen, uppmärksammar produkter som sticker ut för sitt nytänkande, sin funktionalitet och sin användarvänlighet. LetraTag 200B:s utmärkelse b

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye